Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Analysis of Operating Leases

Microsoft Excel

Adjustments to Financial Statements for Operating Leases

Amgen Inc., adjustments to financial statements

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Adjustment to Total Assets
Total assets (as reported) 97,154 65,121 61,165 62,948 59,707
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Total assets (adjusted) 97,154 65,121 61,165 62,948 59,707
Adjustment to Total Debt
Total debt (as reported) 64,613 38,945 33,309 32,986 29,903
Add: Operating lease liability (before adoption of FASB Topic 842)2
Add: Current operating lease liabilities (included in Accrued liabilities) 119 156 145 153 140
Add: Noncurrent operating lease liabilities (included in Other noncurrent liabilities) 691 539 525 306 388
Total debt (adjusted) 65,423 39,640 33,979 33,445 30,431

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1, 2 Equal to total present value of future operating lease payments.


Amgen Inc., Financial Data: Reported vs. Adjusted


Adjusted Financial Ratios for Operating Leases (Summary)

Amgen Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Total Asset Turnover1
Reported total asset turnover 0.28 0.38 0.40 0.39 0.37
Adjusted total asset turnover 0.28 0.38 0.40 0.39 0.37
Debt to Equity2
Reported debt to equity 10.37 10.64 4.97 3.51 3.09
Adjusted debt to equity 10.50 10.83 5.07 3.55 3.15
Return on Assets3 (ROA)
Reported ROA 6.91% 10.06% 9.63% 11.54% 13.13%
Adjusted ROA 6.91% 10.06% 9.63% 11.54% 13.13%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Financial ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Amgen Inc. adjusted total asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023.
Adjusted debt to equity A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity. Amgen Inc. adjusted debt to equity ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. Amgen Inc. adjusted ROA improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023.

Amgen Inc., Financial Ratios: Reported vs. Adjusted


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Selected Financial Data (US$ in millions)
Product sales 26,910 24,801 24,297 24,240 22,204
Total assets 97,154 65,121 61,165 62,948 59,707
Activity Ratio
Total asset turnover1 0.28 0.38 0.40 0.39 0.37
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Product sales 26,910 24,801 24,297 24,240 22,204
Adjusted total assets 97,154 65,121 61,165 62,948 59,707
Activity Ratio
Adjusted total asset turnover2 0.28 0.38 0.40 0.39 0.37

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

1 Total asset turnover = Product sales ÷ Total assets
= 26,910 ÷ 97,154 = 0.28

2 Adjusted total asset turnover = Product sales ÷ Adjusted total assets
= 26,910 ÷ 97,154 = 0.28

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Amgen Inc. adjusted total asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Adjusted Debt to Equity

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Selected Financial Data (US$ in millions)
Total debt 64,613 38,945 33,309 32,986 29,903
Stockholders’ equity 6,232 3,661 6,700 9,409 9,673
Solvency Ratio
Debt to equity1 10.37 10.64 4.97 3.51 3.09
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Adjusted total debt 65,423 39,640 33,979 33,445 30,431
Stockholders’ equity 6,232 3,661 6,700 9,409 9,673
Solvency Ratio
Adjusted debt to equity2 10.50 10.83 5.07 3.55 3.15

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

1 Debt to equity = Total debt ÷ Stockholders’ equity
= 64,613 ÷ 6,232 = 10.37

2 Adjusted debt to equity = Adjusted total debt ÷ Stockholders’ equity
= 65,423 ÷ 6,232 = 10.50

Solvency ratio Description The company
Adjusted debt-to-equity A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity. Amgen Inc. adjusted debt-to-equity ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023.

Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Selected Financial Data (US$ in millions)
Net income 6,717 6,552 5,893 7,264 7,842
Total assets 97,154 65,121 61,165 62,948 59,707
Profitability Ratio
ROA1 6.91% 10.06% 9.63% 11.54% 13.13%
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Net income 6,717 6,552 5,893 7,264 7,842
Adjusted total assets 97,154 65,121 61,165 62,948 59,707
Profitability Ratio
Adjusted ROA2 6.91% 10.06% 9.63% 11.54% 13.13%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × 6,717 ÷ 97,154 = 6.91%

2 Adjusted ROA = 100 × Net income ÷ Adjusted total assets
= 100 × 6,717 ÷ 97,154 = 6.91%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. Amgen Inc. adjusted ROA improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023.